Establishing Clinically Relevant Severity Levels for the Central Sensitization Inventory

被引:184
|
作者
Neblett, Randy [1 ]
Hartzell, Meredith M. [1 ]
Mayer, Tom G. [2 ]
Cohen, Howard [3 ]
Gatchel, Robert J. [4 ]
机构
[1] PRIDE Res Fdn, Dallas, TX USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Orthoped Surg, 5701 Maple Ave 100, Dallas, TX 75235 USA
[3] Univ Texas Arlington, Grad Sch Nursing, Arlington, TX 76019 USA
[4] Univ Texas Arlington, Dept Psychol, Arlington, TX 76019 USA
关键词
central sensitization inventory; central sensitization; central sensitivity syndrome; chronic pain; CENTRAL SENSITIVITY SYNDROMES; OCCUPATIONAL MUSCULOSKELETAL DISORDERS; PAIN DISABILITY QUESTIONNAIRE; IRRITABLE-BOWEL-SYNDROME; PSYCHIATRIC-DISORDERS; FIBROMYALGIA SYNDROME; RISK-FACTORS; DEPRESSION; PREVALENCE; CLASSIFICATION;
D O I
10.1111/papr.12440
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
ObjectivesThe aim of this study was to create and validate severity levels for the central sensitization inventory (CSI), a valid and reliable patient-reported outcome instrument designed to identify patients whose presenting symptoms may be related to a central sensitivity syndrome (CSS; eg, fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome), with a proposed common etiology of central sensitization (CS). MethodsBased on CSI score means and standard deviations from previously published subject samples, the following CSI severity levels were established: subclinical = 0 to 29; mild = 30 to 39; moderate = 40 to 49; severe = 50 to 59; and extreme = 60 to 100. The concurrent validity of the CSI severity levels was then confirmed in a separate chronic pain patient sample (58% with a CSS diagnosis and 42% without) by demonstrating associations between CSI scores and (1) the number of physician-diagnosed CSSs; (2) CSI score distributions in both CSS and non-CSS patient samples; (3) patient-reported history of CSSs; and (4) patient-reported psychosocial measures, which are known to be associated with CSSs. ResultsCompared to the non-CSS patient subsample, the score distribution of the CSS patient subsample was skewed toward the higher severity ranges. CSI mean scores moved into higher severity levels as the number of individual CSS diagnoses increased. Patients who scored in the extreme CSI severity level were more likely to report previous diagnoses of fibromyalgia, chronic fatigue syndrome, temporomandibular joint disorder, tension/migraine headaches, and anxiety or panic attacks (P < 0.01). CSI severity levels were also associated with patient-reported depressive symptoms, perceived disability, sleep disturbance, and pain intensity (P 0.02). ConclusionThis study provides support for these CSI severity levels as a guideline for healthcare providers and researchers in interpreting CSI scores and evaluating treatment responsiveness.
引用
收藏
页码:166 / 175
页数:10
相关论文
共 50 条
  • [1] Establishing Central Sensitization-Related Symptom Severity Subgroups: A Multicountry Study Using the Central Sensitization Inventory
    Cuesta-Vargas, Antonio, I
    Neblett, Randy
    Nijs, Jo
    Chiarotto, Alessandro
    Kregel, Jeroen
    van Wilgen, C. Paul
    Pitance, Laurent
    Knezevic, Aleksandar
    Gatchel, Robert J.
    Mayer, Tom G.
    Viti, Carlotta
    Roldan-Jimenez, Cristina
    Testa, Marco
    Caumo, Wolnei
    Jeremic-Knezevic, Milica
    Nishigami, Tomohiko
    Feliu-Soler, Albert
    Perez-Aranda, Adrian
    Luciano, Juan, V
    PAIN MEDICINE, 2020, 21 (10) : 2430 - 2440
  • [2] Validity of the Central Sensitization Inventory to Address Human Assumed Central Sensitization: Newly Proposed Clinically Relevant Values and Associations
    Schuttert, Ingrid
    Wolff, Andre P.
    Preuper, Rita H. R. Schiphorst
    Malmberg, Alec G. G. A.
    Reneman, Michiel F.
    Timmerman, Hans
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (14)
  • [3] Convergent validity and clinically relevant categories for the Dutch Central Sensitization Inventory in patients with chronic pain
    van der Noord, Robert
    Paap, Davy
    van Wilgen, Cornelis Paul
    JOURNAL OF APPLIED BIOBEHAVIORAL RESEARCH, 2018, 23 (02)
  • [4] The Central Sensitization Inventory (CSI): Establishing Clinically Significant Values for Identifying Central Sensitivity Syndromes in an Outpatient Chronic Pain Sample
    Neblett, Randy
    Cohen, Howard
    Choi, YunHee
    Hartzell, Meredith M.
    Williams, Mark
    Mayer, Tom G.
    Gatchel, Robert J.
    JOURNAL OF PAIN, 2013, 14 (05): : 438 - 445
  • [5] Establishing a clinically relevant cutoff to the Dependency Scale from the dimensional clinical personality inventory
    Carvalho, Lucas de F.
    Pianowski, Giselle
    Filho, Nelson H.
    PSYCHIATRY RESEARCH, 2017, 251 : 26 - 33
  • [6] Sensitization to lupine flour: is it clinically relevant?
    de Jong, N. W.
    van Maaren, M. S.
    Vlieg-Boersta, B. J.
    Dubois, A. E. J.
    de Groot, H.
    van Wijk, R. Gerth
    CLINICAL AND EXPERIMENTAL ALLERGY, 2010, 40 (10): : 1571 - 1577
  • [7] Clinically relevant Sensitization to Pain and Itching
    Schmelz, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 62 - 62
  • [8] Validity of the Central Sensitization Inventory compared with traditional measures of disease severity in fibromyalgia
    Salaffi, Fausto
    Farah, Sonia
    Mariani, Claudia
    Sarzi-Puttini, Piercarlo
    Di Carlo, Marco
    PAIN PRACTICE, 2022, 22 (08) : 702 - 710
  • [9] Validity of the Central Sensitization Inventory compared with traditional measures of disease severity in fibromyalgia
    Salaffi, Fausto
    Farah, Sonia
    Mariani, Claudia
    Sarzi-Puttini, Piercarlo
    Di Carlo, Marco
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (06) : 20 - 20
  • [10] Central sensitization inventory in endometriosis
    Orr, Natasha L.
    Wahl, Kate J.
    Lisonek, Michelle
    Joannou, Angela
    Noga, Heather
    Albert, Arianne
    Bedaiwy, Mohamed A.
    Williams, Christina
    Allaire, Catherine
    Yong, Paul J.
    PAIN, 2022, 163 (02) : E234 - E245